TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
ImmuNeed AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,061
|
1,794
|
1,990 |
| Financial expenses |
13
|
13
|
5 |
| Earnings before taxes |
-719
|
-843
|
-677 |
| EBITDA |
-677
|
-796
|
-634 |
| Total assets |
858
|
1,247
|
989 |
| Current assets |
755
|
1,112
|
826 |
| Current liabilities |
421
|
708
|
674 |
| Equity capital |
395
|
456
|
233 |
| - share capital |
25
|
25
|
18 |
| Employees (average) |
10
|
15
|
14 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
46.0%
|
36.6%
|
23.6% |
| Turnover per employee |
106
|
120
|
142 |
| Profit as a percentage of turnover |
-67.8%
|
-47.0%
|
-34.0% |
| Return on assets (ROA) |
-82.3%
|
-66.6%
|
-67.9% |
| Current ratio |
179.3%
|
157.1%
|
122.6% |
| Return on equity (ROE) |
-182.0%
|
-184.9%
|
-290.6% |
| Change turnover |
-672
|
-203
|
826 |
| Change turnover % |
-39%
|
-10%
|
71% |
| Chg. No. of employees |
-5
|
1
|
4 |
| Chg. No. of employees % |
-33%
|
7%
|
40% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.